BAMF Health Radiopharmacy
We are committed to enhancing patient access to novel radiopharmaceuticals. By fostering robust partnerships with leading pharmaceutical companies, we’re integrating commercial production with clinical trial research at one of the world’s most advanced facilities.
Our state-of-the-art radiopharmacy is equipped with dual cyclotrons, a solid target system, and multiple synthesis platforms, enabling the production of a broad spectrum of PET isotopes. From the initial stages of preclinical development through to commercial release, our expert CDMO team excels in delivering high-volume production with optimal efficiency.
Contract Manufacturing
BAMF Health is driven to make precision medicine accessible to all. Our unmatched flexibility and capacity enable best-in-class availability of unique tracers. By offering the ideal production schedule for your products, we not only accelerate patient access post-FDA approval but also help enhance the speed of market adoption.
We offer comprehensive support for both clinical trial manufacturing and commercial production. Our approach results in seamless transitions from development to delivery, optimizing the impact of your innovations in patient care.
Radiochemistry Development
We understand the importance of a dedicated and experienced team to successfully launch your asset. From the outset, we provide you with a specialized tech transfer team focused on developing, producing, and validating your product.
Leveraging our robust industry partnerships and extensive networks, we streamline processes and regulatory approvals, ensuring swift and successful clinical adoption of your asset.
Radiopharmacy Leadership Team
Join the Radiopharmacy Team
Join us and be part of a growing team of pharmacists, radiochemists, radiation safety experts, and specialists. Our unique setup places our state-of-the-art radiopharmacy right next to our Molecular Imaging Clinic and Molecular Therapy Clinic, giving you the opportunity to engage with the entire spectrum of radiopharmaceutical services—from development to patient care. Build a rewarding career and advance patient access to potentially life-saving therapies all at the same time.
Our Latest News
AI Research at BAMF Health Delivers Powerful Tools for Cancer Detection
Newly published research details BAMF Health’s collaboration with the National Cancer Institute, Leidos Biomedical Research Inc., and Yale University on the Artificial Intelligence and Medical Imaging (AIMI) project.
October 23, 2024
Radiopharm Theranostics and BAMF Health Announce Strategic Collaboration to Manufacture and Dose 18F-RAD 101 for Phase 2b Imaging Study of Brain Metastasis
BAMF Health will be a site for Radiopharma Theranostics’ clinical trial and will also be manufacturing 18F-RAD 101 for other trial sites.
October 21, 2024
Nuclear Medicine Week 2024
In celebration of Nuclear Medicine Week, we’re highlighting our phenomenal team of technologists.
October 5, 2024